Evidence map›Paper›PMID 26005861›Full record

ArticleGene therapy2015

Viral vector-based improvement of optic nerve regeneration: characterization of individual axons' growth patterns and synaptogenesis in a visual target.

B J Yungher, X Luo, Y Salgueiro, M G Blackmore, K K Park

Open access · greenAbstract read
In one paragraph

Article in Gene therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in anJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Engineering anFrontiers in neuroscience · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B J YungherMiami Project to Cure Paralysis, Department of Neurosurgery, University of Miami, Miller School of Medicine, Miami, FL, USA.
X LuoMiami Project to Cure Paralysis, Department of Neurosurgery, University of Miami, Miller School of Medicine, Miami, FL, USA.
Y SalgueiroMiami Project to Cure Paralysis, Department of Neurosurgery, University of Miami, Miller School of Medicine, Miami, FL, USA.
M G BlackmoreDepartment of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
K K ParkMiami Project to Cure Paralysis, Department of Neurosurgery, University of Miami, Miller School of Medicine, Miami, FL, USA.
Marquette University · US

Funding

Regeneration and Reconnection of Damaged Optic NerveR01EY022961 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PARK, KEVIN KYUNG · 2013 to 2019
$2.1M
NEI NIH HHS 1R01EY022961-01NEI NIH HHS R01 EY022961
6 · The paper itself

Abstract

Lack of axon growth ability in the central nervous system poses a major barrier to achieving functional connectivity after injury. Thus, a non-transgenic regenerative approach to reinnervating targets has important implications in clinical and research settings. Previous studies using knockout (KO) mice have demonstrated long-distance axon regeneration. Using an optic nerve injury model, here we evaluate the efficacy of viral, RNA interference (RNAi) and pharmacological approaches that target the phosphatase and tensin homolog (PTEN) and signal transducer and activator of transcription-3 pathways to improve long-distance axon regeneration in wild-type mice. Our data show that adeno-associated virus (AAV) expressing short hairpin RNA (shRNA) against PTEN (shPTEN) enhances retinal ganglion cell axon regeneration after crush injury. However, compared with the previous data in PTEN KO mice, AAV-shRNA results in a lesser degree of regeneration, likely due to incomplete gene silencing inherent to RNAi. In comparison, an extensive enhancement in regeneration is seen when AAV-shPTEN is coupled to AAV encoding ciliary neurotrophic factor (CNTF) and to a cyclic adenosine monophosphate (cAMP) analog, allowing axons to travel long distances and reach their target. We apply whole-tissue imaging that facilitates three-dimensional visualization of single regenerating axons and document heterogeneous terminal patterns in the targets. This shows that some axonal populations generate extensive arbors and make synapses with the target neurons. Collectively, we show a combinatorial viral RNAi and pharmacological strategy that improves long-distance regeneration in wild-type animals and provide single fiber projection data that indicates a degree of preservation of target recognition.

Indexed as

DependovirusGenetic VectorsAnimalsMiceNerve RegenerationNeurogenesisOptic NerveOptic Nerve InjuriesPTEN PhosphohydrolaseRNA, Small InterferingPTEN PhosphohydrolasePTEN protein, humanRNA, Small Interfering

Identifiers

PMID26005861
PMCPMC4600032
OpenAlexW354821716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.